Media Summary: Aditya Bardia, MD, MPH, a medical oncologist at Massachusetts General Hospital and assistant professor of Matthew Milowsky, MD, of the UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, discusses the results of ... This video explains how ADCs work. It describes how they combine targeted

Antibody Drug Conjugate Sacituzumab Govitecan - Detailed Analysis & Overview

Aditya Bardia, MD, MPH, a medical oncologist at Massachusetts General Hospital and assistant professor of Matthew Milowsky, MD, of the UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, discusses the results of ... This video explains how ADCs work. It describes how they combine targeted Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, takes us through a study which evaluated the efficacy ... ... but among the class of drugs that we're getting this real signal in as these new anti-drug Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, discusses the final overall survival (OS) analysis of the Phase ...

This is a patient education video from CancerCare on a type of targeted therapy called “ Joyce A. O'Shaughnessy, MD, and Aditya Bardia, MD, MPH, outline the potential for use of

Photo Gallery

Antibody Drug Conjugate Sacituzumab Govitecan Shows Efficacy in TNBC
Antibody-Drug Conjugates in TNBC: Sacituzumab Govitecan
Antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan
Understanding Antibody Drug Conjugates
Dr. Isaacs Discusses Sacituzumab Govitecan in TNBC
Good responses with antibody-drug conjugate in third-line metastatic TNBC therapy
Understanding Antibody Drug Conjugates
Efficacy of sacituzumab govitecan in mUC by Trop-2 expression
Dr. Isaacs Discusses Antibody Drug Conjugates in TNBC
Final OS analysis of sacituzumab govitecan in TROPiCS-02
Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC
What are ADCs (Antibody-Drug Conjugates)?
View Detailed Profile
Antibody Drug Conjugate Sacituzumab Govitecan Shows Efficacy in TNBC

Antibody Drug Conjugate Sacituzumab Govitecan Shows Efficacy in TNBC

Aditya Bardia, MD, MPH, a medical oncologist at Massachusetts General Hospital and assistant professor of

Antibody-Drug Conjugates in TNBC: Sacituzumab Govitecan

Antibody-Drug Conjugates in TNBC: Sacituzumab Govitecan

Following an analysis of the

Antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan

Antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan

Matthew Milowsky, MD, of the UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, discusses the results of ...

Understanding Antibody Drug Conjugates

Understanding Antibody Drug Conjugates

Dr. Alicia Morgans explains how

Dr. Isaacs Discusses Sacituzumab Govitecan in TNBC

Dr. Isaacs Discusses Sacituzumab Govitecan in TNBC

That the sata2 zmapp

Good responses with antibody-drug conjugate in third-line metastatic TNBC therapy

Good responses with antibody-drug conjugate in third-line metastatic TNBC therapy

... to therapy with a novel

Understanding Antibody Drug Conjugates

Understanding Antibody Drug Conjugates

This video explains how ADCs work. It describes how they combine targeted

Efficacy of sacituzumab govitecan in mUC by Trop-2 expression

Efficacy of sacituzumab govitecan in mUC by Trop-2 expression

Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, takes us through a study which evaluated the efficacy ...

Dr. Isaacs Discusses Antibody Drug Conjugates in TNBC

Dr. Isaacs Discusses Antibody Drug Conjugates in TNBC

... but among the class of drugs that we're getting this real signal in as these new anti-drug

Final OS analysis of sacituzumab govitecan in TROPiCS-02

Final OS analysis of sacituzumab govitecan in TROPiCS-02

Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, discusses the final overall survival (OS) analysis of the Phase ...

Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC

Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC

Source: https://www.spreaker.com/user/7078249/tob-

What are ADCs (Antibody-Drug Conjugates)?

What are ADCs (Antibody-Drug Conjugates)?

This is a patient education video from CancerCare on a type of targeted therapy called “

Antibody-Drug Conjugates in Treating TNBC

Antibody-Drug Conjugates in Treating TNBC

Joyce A. O'Shaughnessy, MD, and Aditya Bardia, MD, MPH, outline the potential for use of